Therapy News and Research

RSS

Study: Less than half of patients receive insurer's approval for prescription of cholesterol drugs

Less than half of patients received their insurer's approval for prescriptions of PCSK9 inhibitors, according to new research in the American Heart Association's journal Circulation.

30 Oct 2017

Researchers isolate new molecule suitable for control of contact allergies

Researchers from the University of Bonn have isolated a molecule that is suitable for the control of contact allergies. The study illuminates a central immune mechanism, which may also play a role in other inflammatory diseases such as arthritis or arteriosclerosis.

30 Oct 2017

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Biogen and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best Biotechnology Product for SPINRAZA (nusinersen). The Prix Galien USA Award recognizes extraordinary achievement in scientific innovation that improves the state of human health. The award was presented at a ceremony in New York City on October 26, 2017.

30 Oct 2017

UK charity Macmillan Cancer hires digital nurse to counter medical misinformation

UK charity Macmillan Cancer, in a move to prevent false news and information circulating among patients, has hired a digital nurse.

29 Oct 2017

Mental health clinicians need to change treatment approach for better engagement of men with depression

The approach to treating men with depression needs to change if their increased uptake of mental health services is to be successful, new research from the University of Sydney shows.

29 Oct 2017

Flu season: UAB experts recommend everyone to receive their yearly influenza vaccine

Flu season is here. The contagious respiratory illness caused by viruses that infect the nose, throat and lungs can cause mild to severe illness and at times may lead to death. People of every age - including people in good health - are at risk for flu.

28 Oct 2017

Cancer researchers make breakthrough in identifying genetic changes during immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That's particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which initially was effective against their tumors.

28 Oct 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

28 Oct 2017

ASA applauds President Trump’s declaration of opioid crisis as public health emergency

The American Society of Anesthesiologists today announced its support of President Donald J. Trump's announcement officially declaring the opioid crisis a public health emergency.

28 Oct 2017

KTU professor granted award by CNS for paradigm shift in neurology

The paper based on the study undertaken by the team of Lithuanian researchers was bestowed Paper of the Year award by The Congress of Neurological Surgeons, USA. The paper "Association of Severe TBI Patients' Outcomes with Duration of Cerebrovascular Autoregulation Impairment Events" was awarded in Neurotrauma & Critical Care section.

28 Oct 2017

New findings offer promising druggable target to root out metastatic pancreatic cancer

Cancer of the pancreas is a deadly disease, with a median survival time of less than six months. Only one in 20 people with pancreatic cancer survives five years past the diagnosis. The reason is the cancer's insidiousness; tumor cells hide deep inside the body, betraying no symptoms until late in the disease, when the cancer has almost invariably spread to other organs.

28 Oct 2017

Clinical trial shows promising results for treatment of patients with recurrent high-grade glioma

New data from a Phase I clinical trial led by Clark Chen, M.D., Ph.D., Lyle French Chair in Neurosurgery and Head of the University of Minnesota Medical School Department of Neurosurgery shows more than a quarter of patients with recurrent high-grade glioma, a form of brain cancer, were alive more than three years after treatment.

28 Oct 2017

Study characterizes hypertensive population with excess weight or obesity and sedentary habits

For the last seven years, researchers in the UPV/EHU's Department of Physical and Sports Education have been studying the hypertensive population with excess weight/obesity and sedentary habits. In a recent publication, this group has determined the state of health of this population through various key physical, physiological, clinical and nutritional markers and has separated them by sex and physical condition.

28 Oct 2017

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient's tumor to inform treatment for these patients in real-time.

27 Oct 2017

Using psychotherapy to treat traumatized refugees

They are suffering from nightmares, flashbacks, depression, or anxiety disorders: refugees coming to Germany from conflict areas are frequently traumatized.

27 Oct 2017

New targeted therapies help relieve symptoms of atopic dermatitis

If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults.

27 Oct 2017

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the world's more diverse populations, according to a study led by the Translational Genomics Research Institute, an affiliate of City of Hope, and the Keck School of Medicine of the University of Southern California.

27 Oct 2017

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

In many metastasized types of cancer, disseminated tumors grow back despite successful chemotherapy. As a research team under the direction of the University of Bern, Switzerland, has now discovered, this is because of isolated cancer cells that survive the chemotherapy due to a phase of dormancy.

27 Oct 2017

Research advance may lead to preservation of hearing in people with Usher syndrome type III

A research advance co-led by Case Western Reserve University School of Medicine's Kumar Alagramam, PhD, may stop the progression of hearing loss and lead to significant preservation of hearing in people with Usher syndrome type III, a form of hereditary hearing loss linked to defects in the sensory "hair" cells in the inner ear. USH3 is caused by a mutation in the clarin-1 gene.

26 Oct 2017

Updated guidelines offer support for appropriate, safe use of accelerated partial-breast irradiation

Cleveland Clinic researcher Chirag Shah, M.D., led the development of updated guidelines for the appropriate and safe utilization of accelerated partial-breast irradiation. The guidelines are published online in the journal, Brachytherapy.

26 Oct 2017

Therapy News and Research

Study: Less than half of patients receive insurer's approval for prescription of cholesterol drugs

Researchers isolate new molecule suitable for control of contact allergies

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

UK charity Macmillan Cancer hires digital nurse to counter medical misinformation

Mental health clinicians need to change treatment approach for better engagement of men with depression

Flu season: UAB experts recommend everyone to receive their yearly influenza vaccine

Cancer researchers make breakthrough in identifying genetic changes during immunotherapy

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

ASA applauds President Trump’s declaration of opioid crisis as public health emergency

KTU professor granted award by CNS for paradigm shift in neurology

New findings offer promising druggable target to root out metastatic pancreatic cancer

Clinical trial shows promising results for treatment of patients with recurrent high-grade glioma

Study characterizes hypertensive population with excess weight or obesity and sedentary habits

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Using psychotherapy to treat traumatized refugees

New targeted therapies help relieve symptoms of atopic dermatitis

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

Research advance may lead to preservation of hearing in people with Usher syndrome type III

Updated guidelines offer support for appropriate, safe use of accelerated partial-breast irradiation

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News